Danone reports 1H revenue EUR 13.76B vs. EUR 14.17B last year

Reports recurring EPS EUR 1.80 vs. EUR 1.76 last year. In H1 2024, consolidated sales stood at EUR 13.757B, up +4.0% on a like-for-like basis, with a balanced contribution from volume/mix and price. On a reported basis, sales decreased by -2.9%, reflecting notably a negative impact from scope and forex, and a positive contribution of hyperinflation. “We have delivered a strong performance for the first half of the year, demonstrating consistency in delivering quality growth: net sales increased by +4.0% on a like-for-like basis, driven by volume/mix up +2.1%, with all categories contributing. We keep driving our category growth, further fueling our winning platforms High Protein, Medical Nutrition, Coffee Creations and Away-from-home. We also remain focused on driving our core portfolio, as reflected by the progressive strengthening of our competitiveness across categories. We continue rebuilding our fundamentals, doubling down on Renew Danone, and have established solid foundations for the “next chapter” of our consumer centric and science-based strategy,” CEO Antoine de Saint-Affrique said.